Reproductive endocrine characteristics of women with epilepsy

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000031563

Enrollment

Unknown

Registered

2020-04-04

Start date

2021-02-01

Completion date

Unknown

Last updated

2020-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

epilepsy, polycystic ovary syndrome

Interventions

control group:antiepileptic drugs

experimental group:antiepileptic drugs and PCOS treatment

Eligibility

Sex/Gender

Female

Age

14 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Aged 14-45 years; 2. Female; 3. Patients diagnosed with epilepsy; 4. Patients willing to sign informed consent.

Exclusion criteria

Exclusion criteria: Nil

Design outcomes

Primary

Measure	Time frame
seizure frequency;EEG;cognitive function;	—

Secondary

Measure	Time frame
imaging characteristics;endocrine hormones;gynecological ultrasonography;	—

Countries

China

Contacts

Public ContactChen Lei

West China Hospital of Sichuan University

leilei_25@126.com+86 18980605819

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026